Journal

Future Oncology

Publication Date

8-1-2022

Volume

18

Issue

24

First Page

2639

Last Page

2649

Document Type

Open Access Publication

DOI

10.2217/fon-2022-0196

0196 Suppl.pdf (11074 kB)
Infographic – Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas

Share

COinS